tiprankstipranks
Immunovant downgraded to Peer Perform from Outperform at Wolfe Research
PremiumThe FlyImmunovant downgraded to Peer Perform from Outperform at Wolfe Research
15d ago
Immunovant price target lowered to $45 from $47 at Wells Fargo
Premium
The Fly
Immunovant price target lowered to $45 from $47 at Wells Fargo
1M ago
3 Best Stocks to Buy Now, 11/21/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 11/21/2024, According to Top Analysts 
2M ago
JPMorgan SMid cap biotech analyst holds an analyst/industry conference call
PremiumThe FlyJPMorgan SMid cap biotech analyst holds an analyst/industry conference call
3M ago
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
Premium
The Fly
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
3M ago
Immunovant resumed with an Outperform at Raymond James
Premium
The Fly
Immunovant resumed with an Outperform at Raymond James
3M ago
Immunovant Advances Groundbreaking Therapy in Graves’ Disease Trials
PremiumCompany AnnouncementsImmunovant Advances Groundbreaking Therapy in Graves’ Disease Trials
4M ago
Roivant Sciences provides update on Graves’ Disease development program
Premium
The Fly
Roivant Sciences provides update on Graves’ Disease development program
4M ago
Immunovant announces update on batoclimab trial, IMVT-1402 IND clearance
Premium
The Fly
Immunovant announces update on batoclimab trial, IMVT-1402 IND clearance
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100